Dr. Kevan Wylie
Professor of Sexual Medicine and Psychiatry, University of Sheffield
President, World Association of Sexual Health
About this event
- Date and time Tue 25 Jun 2019 from 9:00am to 5:30pm
- Location Royal Society of Medicine
- Organised by Sexuality and Sexual Health
This event summarises the state of the art in Female Sexual Dysfunction (FSD) diagnosis and treatment, presenting strategies for collaborative care while also grappling with the ethical issues inherent in FSD management. Join a range of expert speakers in the field as they provide all participants, with the knowledge and tools necessary to provide up-to-date care and advocacy for women’s sexual health concerns.
Why is Female Sexual Dysfunction Interdisciplinary?
Female Sexual Dysfunction is a subject of great and growing interest to healthcare providers and patients alike. Its importance cuts across disciplines: an understanding of FSD is relevant for practitioners of general medicine, gynaecology, urology, and psychiatry. In addition to being an opportunity for creative clinical collaboration, it is also the fulcrum for exciting research in anatomy, endocrinology, neuroscience, and social science.
How does Female Sexual Dysfunction cause controversy?
Many argue that FSD is an 'invented illness' that pathologises and stigmatises normal variation in genital and psychosexual health, motivating unscrupulous “wellness gurus” to sell unproven and even dangerous treatments to vulnerable consumers. This event summarizes the state of the art in FSD diagnosis and treatment, presenting strategies for collaborative care while also grappling with the ethical issues inherent in FSD management.
Other topics include:
- Past, present, and future changes in diagnostic terminology for FSD
- Epidemiology of FSD
- FSD diagnosis and treatment through the stages of sexual response
- Contributions of different clinical disciplines to FSD workup and treatment
- The social and historical context of FSD, providing patient-centred and culturally-informed care
- The scientific evidence for use of popular FSD remedies (e.g. “vaginal rejuvenation” technologies)
Tickets
Standard rates pricing available until 24 June 2019.
Member
| RSM Fellow | RSM Associate | RSM Retired Fellow | RSM Trainee | RSM Student |
|---|---|---|---|---|
| £95.00 | £75.00 | £75.00 | £75.00 | £45.00 |
Non - Member
| Consultant / GP | AHP / Nurse / Midwife | Trainee | Student |
|---|---|---|---|
| £158.00 | £125.00 | £125.00 | £75.00 |
Key speakers
Miss Swati Jha
Consultant gynaecologist at Sheffield Teaching Hospitals, Chair of the British Society of Urogynaecology
Dr. Helen King
Historian, Professor Emerita of Classical Studies at the Open University
Agenda
View the programme
Registration, tea and coffee
Welcome and introduction
Session one: What we talk about when we talk about female sexual dysfunction
Evolution of nomenclature: International classification of diseases vs diagnostic and statistical manual for mental disorders vs diagnostic and statistical manual for mental disorders/international society for the study of women's sexual health
Dr Karl Hollows, Associate Specialist, Sexual Health Medicine and Honorary Clinical Lecturer, Keele University
Epidemiology: Who, what and when?
Dr Kristin Mitchell, Senior Research Fellow, University of Glasgow
"Vaginal rejuvenation" and pseudoscience for sale: A critique
Miss Swati Jha, Consultant Urogynaecologist, Sheffield Teaching Hospitals
Question and answer session
Tea and coffee break
Session two: Dysfunction through the sexual response cycle
Desire dysfunction: Diagnosis and treatments
Dr Karen Gurney, Clinical Psychologist and Psychosexologist and Director, The Havelock Clinic
Arousal dysfunction: Diagnosis and treatments
Ms Claudine Domoney, Clinical Effectiveness Lead and Lead Consultant, Community Gynaecology and Perineal Services, Chelsea and Westminster Hospital NHS Foundation Trust
Orgasm dysfunction: Diagnosis and treatments
Professor Kevan Wylie, President, European Federation of Sexology
Question and answer session
Lunch
Session three: Different approaches to the patient with female sexual dysfunction
Psychotherapist: Workup and treatment
Dr Angela Gregory, Psychosexual Therapist, Nottingham University Hospitals NHS Trust
Physiotherapist: Workup and treatment
Ms Sarah Wolujewicz, Pelvic Floor Physiotherapist, The Havelock Clinic
Medical doctor: Workup and treatment
Dr Penny Goold, Consultant Physician, Genito-Urinary and HIV Medicine, University Hospitals Birmingham NHS Foundation Trust
Question and answer session
Tea and coffee break
Session four: Controversial topics in female sexual dysfunction
Essay prize presentation: Is female sexual dysfunction best considered a medical, psychological or sociocultural problem?
Speaker to be confirmed
Female genital modification: Cultural variation in the vulvar ideal
Dr Sharon Dixon, National Institute for Health Research In-Practice Fellow, Nuffield Department of Primary Care Health Sciences
Medicalisation of female sexual dysfunction: A historical perspective
Professor Helen King, Professor Emerita, Classical Studies, The Open University and Visiting Professor, Politics and International Studies, University of Warwick
Question and answer session
Future topics
Close of meeting
Location
Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE, United Kingdom